Economic assessment of an anti-HCV screening program in Italy

Silvia Coretti; Antonio Gasbarrini; Americo Cicchetti

doi:10.1016/j.jval.2013.07.005

Economic assessment of an anti-HCV screening program in Italy

Silvia Coretti, Antonio Gasbarrini, Americo Cicchetti

Risultato della ricerca: Contributo in rivista › Articolo in rivista

25 Citazioni (Scopus)

Abstract

The progression of hepatitis C virus (HCV) disease usually occurs over a 10-year period. HCV-related complications as well as the highly debilitating effects on patients represent a significant item of expenditure for the National Health Service. Early detection of HCV infection is an excellent opportunity to improve patients' quality of life and to rationalize resource allocation.

Lingua originale	English
pagine (da-a)	965-972
Numero di pagine	8
Rivista	Value in Health
Volume	16
DOI	https://doi.org/10.1016/j.jval.2013.07.005
Stato di pubblicazione	Pubblicato - 2013

Keywords

Adolescent
Adult
Aged
Cost-Benefit Analysis
Genotype
Health Resources
Hepacivirus
Hepatitis C Antibodies
Hepatitis C, Chronic
Humans
Italy
Markov Chains
Markov model
Mass Screening
Middle Aged
Monte Carlo Method
National Health Programs
Young Adult
cost-effectiveness
liver disease

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1016/j.jval.2013.07.005

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{f86c1c49bae14323a1d956f9e81360e3,

title = "Economic assessment of an anti-HCV screening program in Italy",

abstract = "The progression of hepatitis C virus (HCV) disease usually occurs over a 10-year period. HCV-related complications as well as the highly debilitating effects on patients represent a significant item of expenditure for the National Health Service. Early detection of HCV infection is an excellent opportunity to improve patients' quality of life and to rationalize resource allocation.",

keywords = "Adolescent, Adult, Aged, Cost-Benefit Analysis, Genotype, Health Resources, Hepacivirus, Hepatitis C Antibodies, Hepatitis C, Chronic, Humans, Italy, Markov Chains, Markov model, Mass Screening, Middle Aged, Monte Carlo Method, National Health Programs, Young Adult, cost-effectiveness, liver disease, Adolescent, Adult, Aged, Cost-Benefit Analysis, Genotype, Health Resources, Hepacivirus, Hepatitis C Antibodies, Hepatitis C, Chronic, Humans, Italy, Markov Chains, Markov model, Mass Screening, Middle Aged, Monte Carlo Method, National Health Programs, Young Adult, cost-effectiveness, liver disease",

author = "Silvia Coretti and Antonio Gasbarrini and Americo Cicchetti",

year = "2013",

doi = "10.1016/j.jval.2013.07.005",

language = "English",

volume = "16",

pages = "965--972",

journal = "Value in Health",

issn = "1098-3015",

publisher = "Blackwell Science Incorporated:350 Main Street, Sixth Floor:Malden, MA 02148:(888)661-5800, (781)388-8250, EMAIL: [email protected], INTERNET: http://www.blackwell-science.com, Fax: (781)388-8232",

}

TY - JOUR

T1 - Economic assessment of an anti-HCV screening program in Italy

AU - Coretti, Silvia

AU - Gasbarrini, Antonio

AU - Cicchetti, Americo

PY - 2013

Y1 - 2013

N2 - The progression of hepatitis C virus (HCV) disease usually occurs over a 10-year period. HCV-related complications as well as the highly debilitating effects on patients represent a significant item of expenditure for the National Health Service. Early detection of HCV infection is an excellent opportunity to improve patients' quality of life and to rationalize resource allocation.

AB - The progression of hepatitis C virus (HCV) disease usually occurs over a 10-year period. HCV-related complications as well as the highly debilitating effects on patients represent a significant item of expenditure for the National Health Service. Early detection of HCV infection is an excellent opportunity to improve patients' quality of life and to rationalize resource allocation.

KW - Adolescent

KW - Adult

KW - Aged

KW - Cost-Benefit Analysis

KW - Genotype

KW - Health Resources

KW - Hepacivirus

KW - Hepatitis C Antibodies

KW - Hepatitis C, Chronic

KW - Humans

KW - Italy

KW - Markov Chains

KW - Markov model

KW - Mass Screening

KW - Middle Aged

KW - Monte Carlo Method

KW - National Health Programs

KW - Young Adult

KW - cost-effectiveness

KW - liver disease

KW - Adolescent

KW - Adult

KW - Aged

KW - Cost-Benefit Analysis

KW - Genotype

KW - Health Resources

KW - Hepacivirus

KW - Hepatitis C Antibodies

KW - Hepatitis C, Chronic

KW - Humans

KW - Italy

KW - Markov Chains

KW - Markov model

KW - Mass Screening

KW - Middle Aged

KW - Monte Carlo Method

KW - National Health Programs

KW - Young Adult

KW - cost-effectiveness

KW - liver disease

UR - http://hdl.handle.net/10807/60560

U2 - 10.1016/j.jval.2013.07.005

DO - 10.1016/j.jval.2013.07.005

M3 - Article

SN - 1098-3015

VL - 16

SP - 965

EP - 972

JO - Value in Health

JF - Value in Health

ER -

Economic assessment of an anti-HCV screening program in Italy

Abstract

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo